Point72 Asset Management’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
VCM
VPM
Point72 Asset Management's IDXX Position: Q1 2026 in Review
Point72 Asset Management increased its Idexx Laboratories (IDXX) stake by 1,054% in Q1 2026, buying an estimated $75.7M and bringing the position to 129,284 shares worth $72.6M. The position accounts for 0.09% of the portfolio, ranked #248.
Point72 Asset Management first reported a position in IDXX in Q1 2015 and has held it in 16 quarters since. The position peaked at $78M in Q4 2023. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Point72 Asset Management held 129,284 shares of Idexx Laboratories worth $72.6M as of Q1 2026.
- Point72 Asset Management bought 118,080 Idexx Laboratories shares in Q1 2026, an estimated $75.7M.
- Idexx Laboratories made up 0.09% of Point72 Asset Management's portfolio in Q1 2026, its #248 holding.
- Point72 Asset Management first reported a position in Idexx Laboratories in Q1 2015 and has held it in 16 quarters since.
- Point72 Asset Management's Idexx Laboratories position peaked at $78M in Q4 2023.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.